Company
Headquarters: Kiryat Tivon, Israel
CEO: Mr. Gil Paramedic
₪7.7 Million
ILS as of Jan. 1, 2023
US$2.2 Million
Company | Market Cap (USD) |
---|---|
Zoetis Inc. | $89.09 B |
MERCK Kommanditgesellschaft auf Aktien | $67.64 B |
Takeda Pharmaceutical Company Limited | $47.71 B |
Haleon plc | $38.90 B |
PPD, Inc. | $16.58 B |
Company | Market Cap (USD) |
---|---|
Lilly | $586.39 B |
UnitedHealth Group | $504.47 B |
Novo Nordisk | $461.52 B |
Johnson & Johnson | $387.50 B |
Merck | $296.51 B |
Pharmocann Global Ltd engages in the multiplication, cultivation, production, and sale of cannabis for medical purposes. The company provides TAVOR, JERUSALEM, CARMEL, CANAAN, MERON, HERMON, and MEGIDO for treatment of depression, insomnia, migraines, chronic pain, sleeplessness, post trauma, anxiety, combat stress, crohn's disease, indigestion, fatigue, cancer, chemotherapy, alzheimer, multiple sclerosis, arthritis, sleeplessness, pain, lack of appetite, and muscular dystrophy. It produces 3.5 tons of medical cannabis yearly and serves Israel, Australia, Asia, Europe, the United States, Canada, and internationally. It also produces and distributes hemp seed oil products. The company was formerly known as Medical Compression System (DBN) Ltd. and changed its name to Pharmocann Global Ltd. Pharmocann Global Ltd was incorporated in 1997 and is headquartered in Kiryat Tivon, Israel.
Top 1-year algo backtest: +269.94%
$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Pharmocann Global Ltd has the following listings and related stock indices.
Stock: TASE: PMCN wb_incandescent